TY - JOUR
T1 - Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
AU - Kumar, Vivek
AU - Yarravarapu, Nageswari
AU - Lapinsky, David J.
AU - Perley, Danielle
AU - Felts, Bruce
AU - Tomlinson, Michael J.
AU - Vaughan, Roxanne A.
AU - Henry, L. Keith
AU - Lever, John R.
AU - Newman, Amy Hauck
N1 - Publisher Copyright:
© 2015 American Chemical Society.
PY - 2015/7/23
Y1 - 2015/7/23
N2 - Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were synthesized based on the selective serotonin reuptake inhibitor (SSRI), (S)-citalopram (1). The classic 4-azido-3-iodo-phenyl group was appended to either the C-1 or C-5 position of the parent molecule, with variable-length linkers, to generate ligands 15, 22, and 26. These ligands retained high to moderate affinity binding (Ki = 24-227 nM) for hSERT, as assessed by [3H]5-HT transport inhibition. When tested against Ser438Thr hSERT, all three PALs showed dramatic rightward shifts in inhibitory potency, with Ki values ranging from 3.8 to 9.9 μM, consistent with the role of Ser438 as a key residue for high-affinity binding of many SSRIs, including (S)-citalopram. Photoactivation studies demonstrated irreversible adduction to hSERT by all ligands, but the reduced (S)-citalopram inhibition of labeling by [125I]15 compared to that by [125I]22 and [125I]26 suggests differences in binding mode(s). These radioligands will be useful for characterizing the drug-protein binding interactions for (S)-citalopram at hSERT.
AB - Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were synthesized based on the selective serotonin reuptake inhibitor (SSRI), (S)-citalopram (1). The classic 4-azido-3-iodo-phenyl group was appended to either the C-1 or C-5 position of the parent molecule, with variable-length linkers, to generate ligands 15, 22, and 26. These ligands retained high to moderate affinity binding (Ki = 24-227 nM) for hSERT, as assessed by [3H]5-HT transport inhibition. When tested against Ser438Thr hSERT, all three PALs showed dramatic rightward shifts in inhibitory potency, with Ki values ranging from 3.8 to 9.9 μM, consistent with the role of Ser438 as a key residue for high-affinity binding of many SSRIs, including (S)-citalopram. Photoactivation studies demonstrated irreversible adduction to hSERT by all ligands, but the reduced (S)-citalopram inhibition of labeling by [125I]15 compared to that by [125I]22 and [125I]26 suggests differences in binding mode(s). These radioligands will be useful for characterizing the drug-protein binding interactions for (S)-citalopram at hSERT.
UR - http://www.scopus.com/inward/record.url?scp=84937685275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937685275&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.5b00682
DO - 10.1021/acs.jmedchem.5b00682
M3 - Article
C2 - 26153715
AN - SCOPUS:84937685275
SN - 0022-2623
VL - 58
SP - 5609
EP - 5619
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 14
ER -